These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 28151504)

  • 61. [Antiphospholipid syndrome and antiphospholipid antibodies as a risk factors of ischaemic heart disease and myocardial infarction in patients with systemic lupus erythematosus].
    Ostanek L; Brzosko M; Fischer K; Płohska E
    Pol Arch Med Wewn; 2006 May; 115(5):407-13. PubMed ID: 17195352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors.
    Pérez-Vázquez ME; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1992 Apr; 92(4):357-62. PubMed ID: 1558081
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E; Durieu I; Cochat P; Vital Durand D; Ninet J; Fabien N; Cimaz R
    Rheumatology (Oxford); 2008 Feb; 47(2):183-7. PubMed ID: 18160418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
    Riancho-Zarrabeitia L; Martínez-Taboada VM; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Mena Vázquez N; Calvo-Alén J; Menor Almagro R; Tomero Muriel E; Uriarte Isacelaya E; Boteanu A; Andres M; Freire González M; Santos Soler G; Ruiz-Lucea ME; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez J; Expósito L; Hernández Beriaín JA; Horcada L; Aurrecoechea E; Pego Reigosa JM
    Clin Exp Rheumatol; 2021; 39(3):555-563. PubMed ID: 32828148
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Relations beetwen severity of anemia and certain antiphospholipid antibodies presence in systemic lupus erythematosus patients].
    Suszek D; Majdan M; Chudzik D; Dryglewska M
    Pol Arch Med Wewn; 2006 May; 115(5):426-31. PubMed ID: 17195355
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients.
    Gkrouzman E; Peng M; Davis-Porada J; Kirou KA
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):656-664. PubMed ID: 33171010
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
    Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
    Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
    Pericleous C; D'Souza A; McDonnell T; Ripoll VM; Leach O; Isenberg D; Giles I; Rahman A
    Rheumatology (Oxford); 2020 Jan; 59(1):146-152. PubMed ID: 31257438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
    Marziale A; Bettacchioli E; Picart G; Nafai S; Galinat H; Meroni PL; Frostegard J; ; Alarcon-Riquelme ME; Renaudineau Y
    J Autoimmun; 2020 Dec; 115():102524. PubMed ID: 32693965
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK; Nagy E; Bodó I; Mohl A; Gergely P
    Scand J Rheumatol; 2007; 36(3):198-205. PubMed ID: 17657674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M; Hiam KM; Edmond C; Assem E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.
    Moroni G; Ventura D; Riva P; Panzeri P; Quaglini S; Banfi G; Simonini P; Bader R; Meroni PL; Ponticelli C
    Am J Kidney Dis; 2004 Jan; 43(1):28-36. PubMed ID: 14712424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
    PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.